GeneDx Holdings (WGS) Misses Q2 EPS by 14c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts WGS Hot Sheet
Join SI Premium – FREE
GeneDx Holdings (NASDAQ: WGS) reported Q2 EPS of ($0.28), $0.14 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $114.4 million versus the consensus estimate of $111.01 million.
GUIDANCE:
GeneDx Holdings sees Q3 2026 revenue of $122-124 million, versus the consensus of $126 million.
GeneDx Holdings sees FY2026 revenue of $475-490 million, versus the consensus of $478.4 million.
For earnings history and earnings-related data on GeneDx Holdings (WGS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ONEOK (OKE) Tops Q3 EPS by 63c; raises guidance
- Baker Hughes Company (BKR) Tops Q3 EPS by 10c
- EXL (EXLS) Tops Q3 EPS by 6c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
